-
Je něco špatně v tomto záznamu ?
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death
L. Kasikova, I. Truxova, I. Cremer, C. Sautes-Fridman, O. Kepp, G. Kroemer, R. Spisek, J. Fucikova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- imunogenní buněčná smrt * MeSH
- imunohistochemie metody MeSH
- kalretikulin analýza imunologie MeSH
- lidé MeSH
- nádorové biomarkery analýza imunologie MeSH
- nádorové mikroprostředí MeSH
- nádory imunologie patologie MeSH
- průtoková cytometrie metody MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
Immunogenic cell death (ICD), a functionally peculiar type of apoptosis, represents a unique way to deliver danger-associated molecular patterns (DAMPs) to the tumor microenvironment. Once emitted by dying cancer cells, DAMPs orchestrate antigen-specific immune responses by acting on both innate and adaptive components of the immune system. Accumulating preclinical and clinical evidence indicates that one of these DAMPs, calreticulin (CALR) represents a novel powerful prognostic biomarker, reflecting the activation of a clinically relevant anticancer immune response in different cancer malignancies. Therefore, the assessment of CALR emission can provide a therapeutic tool for the stratification of cancer patients and the identification of individuals that are intrinsically capable to respond to a particular treatment. Here we describe methods for the quantification of CALR exposure in the tumor microenvironment of cancer patients by flow cytometry and immunohistochemistry.
Metabolomics and Cell Biology Platforms Institut Gustave Roussy Villejuif France
Pôle de Biologie Hôpital Européen Georges Pompidou AP HP Paris France
Sorbonne Université Paris France
Suzhou Institute for Systems Biology Chinese Academy of Sciences Suzhou China
Team Inflammation Complement and Cancer INSERM Centre de Recherche des Cordeliers Paris France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028650
- 003
- CZ-PrNML
- 005
- 20210114154557.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/bs.mie.2019.05.025 $2 doi
- 035 __
- $a (PubMed)32000894
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kasikova, Lenka $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic.
- 245 10
- $a Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death / $c L. Kasikova, I. Truxova, I. Cremer, C. Sautes-Fridman, O. Kepp, G. Kroemer, R. Spisek, J. Fucikova,
- 520 9_
- $a Immunogenic cell death (ICD), a functionally peculiar type of apoptosis, represents a unique way to deliver danger-associated molecular patterns (DAMPs) to the tumor microenvironment. Once emitted by dying cancer cells, DAMPs orchestrate antigen-specific immune responses by acting on both innate and adaptive components of the immune system. Accumulating preclinical and clinical evidence indicates that one of these DAMPs, calreticulin (CALR) represents a novel powerful prognostic biomarker, reflecting the activation of a clinically relevant anticancer immune response in different cancer malignancies. Therefore, the assessment of CALR emission can provide a therapeutic tool for the stratification of cancer patients and the identification of individuals that are intrinsically capable to respond to a particular treatment. Here we describe methods for the quantification of CALR exposure in the tumor microenvironment of cancer patients by flow cytometry and immunohistochemistry.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádorové biomarkery $x analýza $x imunologie $7 D014408
- 650 _2
- $a kalretikulin $x analýza $x imunologie $7 D037282
- 650 _2
- $a průtoková cytometrie $x metody $7 D005434
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a imunogenní buněčná smrt $7 D000079527
- 650 _2
- $a imunohistochemie $x metody $7 D007150
- 650 _2
- $a nádory $x imunologie $x patologie $7 D009369
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Truxova, Iva $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic.
- 700 1_
- $a Cremer, Isabelle $u Team Inflammation, Complement and Cancer, INSERM, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Université, Paris, France.
- 700 1_
- $a Sautes-Fridman, Catherine $u Team Inflammation, Complement and Cancer, INSERM, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Université, Paris, France.
- 700 1_
- $a Kepp, Oliver $u Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Descartes, Université Sorbonne Paris Cité, Université Paris Diderot, Sorbonne Université, INSERM, Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
- 700 1_
- $a Kroemer, Guido $u Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Descartes, Université Sorbonne Paris Cité, Université Paris Diderot, Sorbonne Université, INSERM, Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Suzhou Institute for Systems Biology, Chinese Academy of Sciences, Suzhou, China; Department of Women's and Children's Health, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Spisek, Radek $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic.
- 700 1_
- $a Fucikova, Jitka $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic. Electronic address: fucikova@sotio.com.
- 773 0_
- $w MED00008502 $t Methods in enzymology $x 1557-7988 $g Roč. 632, č. - (2020), s. 15-25
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32000894 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154553 $b ABA008
- 999 __
- $a ok $b bmc $g 1608985 $s 1119830
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 632 $c - $d 15-25 $e 20190708 $i 1557-7988 $m Methods in enzymology $n Methods Enzymol $x MED00008502
- LZP __
- $a Pubmed-20210105
